Join us on Thursday 26 February for our next webinar on the diagnostics revolution.
Time and accuracy issues, stigma, and a lack of specialist capacity, have been major barriers to diagnosis for Alzheimer’s disease and related dementias. In recent times we have been on the cusp of revolution in diagnostics and have been calling on health system preparedness and readiness. That diagnostics revolution, that we envisaged and hoped for, is happening right now!
Following on from ADI’s End of Year Forecast event in December 2025, we are now bringing together the leading lights in this rapidly emerging diagnostics space, no longer to ask ‘are we ready’ but how are these new diagnostics being implemented, how are clinics and health systems integrating them, what are the barriers and solutions to their use, what are the training gaps and who is leading and innovating in the space.
Join us on 26 February to hear from a leading panel of experts about how new blood tests (blood-based biomarkers) are being introduced and integrated, advancements in CSF (cerebral spine fluid) testing, digital biomarkers in practice and the emergence of online and at home cognitive testing. Learn more about roll out plans for these new tools, about regulation and about reimbursement.
Underpinning all of this we will also hear from a person living with dementia, who has first-hand experience of the diagnostics pathway and true insight into how these emerging new tools can improve and set a new standard for diagnosis.
We will also shine a light on how diagnostics are changing the face of clinical trial recruitment and we will get invaluable insight into how one research project is testing the new blood tests in practice, tackling training alongside testing accuracy and efficacy.
Join this webinar and to put your question to our expert panel.